Literature DB >> 21270063

Guillain-Barré syndrome subtypes related to Campylobacter infection.

Judith Drenthen1, Nobuhiro Yuki, Jan Meulstee, Ellen M Maathuis, Pieter A van Doorn, Gerhard H Visser, Joleen H Blok, Bart C Jacobs.   

Abstract

BACKGROUND: In Guillain-Barré syndrome (GBS), the diversity in electrophysiological subtypes is unexplained but may be determined by geographical factors and preceding infections. Acute motor axonal neuropathy (AMAN) is a frequent GBS variant in Japan and one study proposed that in Japan, Campylobacter jejuni infections exclusively elicit AMAN. In The Netherlands C jejuni is the predominant type of preceding infection yet AMAN is rare. This may indicate that not all Dutch GBS patients with C jejuni infections have AMAN.
OBJECTIVE: To determine if GBS patients with a preceding C jejuni infection in The Netherlands exclusively have AMAN.
METHODS: Retrospective analysis of preceding infections in relation to serial electrophysiology and clinical data from 123 GBS patients. C jejuni related cases were defined as having preceding diarrhoea and positive C jejuni serology. Electrophysiological characteristics in C jejuni related cases were compared with those in viral related GBS patients. In addition, eight GBS patients from another cohort with positive stool cultures for C jejuni were analysed.
RESULTS: 17 (14%) of 123 patients had C jejuni related GBS. C jejuni patients had lower motor and higher sensory action potentials compared with viral related cases. Nine (53%) C jejuni patients had either AMAN or inexcitable nerves. However, three (18%) patients fulfilled the criteria for acute inflammatory demyelinating polyneuropathy (AIDP). Also, two (25%) of eight additional patients with a C jejuni positive stool sample had AIDP.
CONCLUSION: In The Netherlands, C jejuni infections are strongly, but not exclusively, associated with axonal GBS. Some patients with these infections fulfil current criteria for demyelination.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21270063     DOI: 10.1136/jnnp.2010.226639

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  19 in total

1.  Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.

Authors:  Christiane Caudie; Arnaud Quittard Pinon; Didier Taravel; Valérie Sivadon-Tardy; David Orlikowski; Flore Rozenberg; Tarek Sharshar; Jean Claude Raphaël; Jean Louis Gaillard
Journal:  J Neurol       Date:  2011-04-24       Impact factor: 4.849

2.  Guillain-Barré Syndrome in India: population-based validation of the Brighton criteria.

Authors:  Farrah J Mateen; David R Cornblath; Hamid Jafari; Russell T Shinohara; Devendra Khandit; Bina Ahuja; Sunil Bahl; Roland W Sutter
Journal:  Vaccine       Date:  2011-10-11       Impact factor: 3.641

Review 3.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 4.  Infection and autoimmune disease.

Authors:  Asli Gamze Sener; Ilhan Afsar
Journal:  Rheumatol Int       Date:  2012-07-19       Impact factor: 2.631

5.  Higher frequencies of HLA DQB1*05:01 and anti-glycosphingolipid antibodies in a cluster of severe Guillain-Barré syndrome.

Authors:  L Schirmer; V Worthington; U Solloch; V Loleit; V Grummel; N Lakdawala; D Grant; R Wassmuth; A H Schmidt; F Gebhardt; T F M Andlauer; J Sauter; A Berthele; M P Lunn; Bernhard Hemmer
Journal:  J Neurol       Date:  2016-08-02       Impact factor: 4.849

6.  Neurologic symptoms associated with cattle farming in the agricultural health study.

Authors:  Leora Vegosen; Meghan F Davis; Ellen Silbergeld; Patrick N Breysse; Jacqueline Agnew; Gregory Gray; Laura Beane Freeman; Freya Kamel
Journal:  J Occup Environ Med       Date:  2012-10       Impact factor: 2.162

7.  Miller Fisher syndrome linked to Norovirus infection.

Authors:  Taro Shimizu; Yasuharu Tokuda
Journal:  BMJ Case Rep       Date:  2012-12-14

Review 8.  Axonal variants of Guillain-Barré syndrome: an update.

Authors:  Pei Shang; Mingqin Zhu; Ying Wang; Xiangyu Zheng; Xiujuan Wu; Jie Zhu; Jiachun Feng; Hong-Liang Zhang
Journal:  J Neurol       Date:  2020-03-05       Impact factor: 4.849

Review 9.  Proximal nerve lesions in early Guillain-Barré syndrome: implications for pathogenesis and disease classification.

Authors:  José Berciano; María J Sedano; Ana L Pelayo-Negro; Antonio García; Pedro Orizaola; Elena Gallardo; Miguel Lafarga; María T Berciano; Bart C Jacobs
Journal:  J Neurol       Date:  2016-06-17       Impact factor: 4.849

10.  Binational outbreak of Guillain-Barré syndrome associated with Campylobacter jejuni infection, Mexico and USA, 2011.

Authors:  B R Jackson; J Alomía Zegarra; H López-Gatell; J Sejvar; F Arzate; S Waterman; A Sánchez Núñez; B López; J Weiss; R Quintero Cruz; D Y López Murrieta; R Luna-Gierke; K Heiman; A R Vieira; C Fitzgerald; P Kwan; M Zárate-Bermúdez; D Talkington; V R Hill; B Mahon
Journal:  Epidemiol Infect       Date:  2013-08-07       Impact factor: 4.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.